The Minimally Invasive Gastrointestinal Surgical Systems Market Size is valued at USD 5.75 billion in 2023 and is predicted to reach USD 9.88 billion by the year 2031 at a 7.2% CAGR during the forecast period for 2024-2031.
Minimally invasive gastrointestinal surgical systems allow for exact surgeries with small cuts, which speeds up recovery and lowers the risk of complications. Minimally invasive gastrointestinal surgery systems are becoming more popular due to the rising need for shorter hospital stays and quicker recovery times. Modern surgical techniques that improve results while minimizing patient discomfort are in high demand due to the increasing prevalence of gastrointestinal illnesses such as colorectal cancer and gastroesophageal reflux disease. Moreover, growing knowledge of the benefits of minimally invasive treatments, such as shorter recovery periods and fewer problems, drives demand even further. In addition, the growing complexity in clinical decision-making, the huge workload of doctors, huge investments in research and development and building up healthcare infrastructure, and more and more positive outcomes from minimally invasive surgeries are all factors that are making the market grow even more. Moreover, the facilities of minimally invasive gastrointestinal surgical systems are encouraged by supportive government policies and incentives.
However, the high procedural costs, restricted access to sophisticated healthcare in underdeveloped areas, and lack of expertise limit the market growth. Additionally, market growth for minimally invasive gastrointestinal surgical systems was temporarily dampened by the COVID-19 epidemic, as patients delayed elective procedures. Faster recovery methods were prioritized by hospitals post-pandemic in an effort to decrease patient stays and efficiently handle delays, which led to a boom in demand. Additionally, the regional market is seeing a proliferation of partnerships and strategic alliances, which is leading to exciting potential for growth worldwide.
Competitive Landscape
Some Major Key Players In The Minimally Invasive Gastrointestinal Surgical Systems Market:
- Braun Melsungen AG
- Conmed Corporation
- Karl Storz SE & Co. KG
- Medtronic plc
- Olympus Corporation
- Stryker Corporation
- TransEnterix, Inc.
- Boston Scientific Corporation
- Cook Medical, Inc.
- Richard Wolf GmbH
- Intuitive Surgical, Inc.
- Ambu A/S
- Schölly Fiber Optic GmbH
- Xenocor, Inc.
- Fujifilm Holdings Corporation
- Pentax Medical (Hoya Corporation)
- Smith & Nephew,
- Abbott,
- Applied Biomedical, LLC
- Aesculap, Inc.,
- Johnson & Johnson Services, Inc.,
- Novatract Surgical Inc.,
- REMA Medizintechnik GmbH,
- Teleflex Incorporated,
- Other Market Players
Market Segmentation:
The minimally invasive gastrointestinal surgical systems market is segmented based on product type, surgery, and end-user. Based on product type, the market includes Conventional Minimally Invasive Gastrointestinal Surgical Systems (MISS) (Endoscopes and Endoscopy Systems (Rigid Endoscopes, Flexible Endoscopes, Capsule Endoscopy (Workstations and Data Recorders, Capsules, Others)), Videoscopes, Endoscopy Ultrasound, Therapeutic Energy Devices, Point of Sales), Surgical Robotics (Robotic Systems, Robotic Surgery Instruments and Accessories, Services. By surgery, the market is segmented into adrenalectomy, appendectomy, bariatric surgery, cholecystectomy, colon & rectal surgery, foregut surgery, hernia repair, and others. By end-user, the market is segmented into speciality clinics, hospitals, and ambulatory surgical centres.
Based On The Product, The Surgical Robotics Segment Accounts For A Major Contributor To The Minimally Invasive Gastrointestinal Surgical Systems Market.
Surgical robotics are expected to hold a major global market share in 2023 in the minimally invasive gastrointestinal surgical systems market because of their accuracy, better patient results, and shorter recuperation periods. Surgeons now execute intricate surgeries with greater precision and control using these technologies, all while minimizing pain and accelerating the healing process through the use of small incisions. Their market growth is bolstered by developments in robotic technology and the growing number of hospitals that utilize them.
Hospitals Segment To Witnessed A Rapid Growth.
The hospital segment is growing because less invasive operations, shorter hospital stays, and quicker recoveries are becoming more popular among patients. To boost patient satisfaction and, ultimately, their number of patients, hospitals are implementing cutting-edge surgical technologies. Healthcare facilities are also motivated to purchase this cutting-edge surgical equipment due to the increasing number of gastrointestinal ailments.
In The Region, The North American Minimally Invasive Gastrointestinal Surgical Systems Market Holds A Significant Revenue Share.
The North American minimally invasive gastrointestinal surgical systems market is expected to report very large market share in revenue in the near future. This can be attributed to the fact that it is experiencing a boom in healthcare spending, a rise in healthcare outcomes, a surge in the number of patients requiring minimally invasive surgical procedures, and an increase in the number of people older people. In addition, the Asia Pacific is expected to grow rapidly in the minimally invasive gastrointestinal surgical systems market because of rising healthcare expenditures, greater awareness of minimally invasive procedures, a growing patient population, and technological advancements in medical field in this region.
Minimally Invasive Gastrointestinal Surgical Systems Market Report Scope
Report Attribute |
Specifications |
Market Size Value In 2023 |
USD 5.75 Bn |
Revenue Forecast In 2031 |
USD 9.88 Bn |
Growth Rate CAGR |
CAGR of 7.2% from 2024 to 2031 |
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
Historic Year |
2019 to 2023 |
Forecast Year |
2024-2031 |
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
Segments Covered |
By Product Type, Surgery, And End-User |
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
Competitive Landscape |
B. Braun Melsungen AG, Conmed Corporation, Karl Storz SE & Co. KG, Medtronic plc, Olympus Corporation, Stryker Corporation, TransEnterix, Inc, Boston Scientific Corporation, Cook Medical, Inc, Richard Wolf GmbH, Intuitive Surgical, Inc, Ambu A/S, Schölly Fiber Optic GmbH, Xenocor, Inc, Fujifilm Holdings Corporation, Pentax Medical (Hoya Corporation) and Others |
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |